Synergy of isoflurane preconditioning and propofol postconditioning reduces myocardial reperfusion injury in patients

Clinical Science

Volumn 121, Issue 2, 2011, Pages 57-69

  Huang, Zhiyong ^a,b,c   Zhong, Xingwu ^d   Irwin, Michael G ^b   Ji, Shangyi ^a   Wong, Gordon T ^b   Liu, Yanan ^b   Xia, Zhong Yuan ^c   Finegan, Barry A ^e   Xia, Zhengyuan ^b,c  

^a Sun Yat sen Cardiovascular Hospital   (China)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^d SUN YAT SEN UNIVERSITY   (China)

^e UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Coronary artery bypass graft surgery; Isoflurane; Myocardial reperfusion injury; Postconditioning; Preconditioning

Indexed keywords

3 NITROTYROSINE; ADRENALIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOPAMINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ETOMIDATE; FATTY ACID BINDING PROTEIN; FENTANYL; GLYCERYL TRINITRATE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; ISOFLURANE; MIDAZOLAM; NITRATE; PANCURONIUM BROMIDE; PROPOFOL; SUPEROXIDE DISMUTASE; TROPONIN I; TUMOR NECROSIS FACTOR;

ADULT; AGED; ANESTHESIA INDUCTION; ANESTHETIC RECOVERY; AORTA CLAMPING; AREA UNDER THE CURVE; ARTERIAL PRESSURE; ARTICLE; BODY WEIGHT; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; CAROTID ENDARTERECTOMY; CENTRAL VENOUS PRESSURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL PROTOCOL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CONVALESCENCE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY THROMBOSIS; CORONARY HEMODYNAMICS; CREATINE KINASE BLOOD LEVEL; DEATH; DIABETES MELLITUS; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG POTENTIATION; ELECTROCARDIOGRAPHY; END TIDAL CARBON DIOXIDE TENSION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISCHEMIC POSTCONDITIONING; ISCHEMIC PRECONDITIONING; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PULMONARY ARTERY OCCLUSION PRESSURE; REPERFUSION INJURY; RIGHT CORONARY ARTERY; ST SEGMENT; WESTERN BLOTTING;

EID: 79955583602     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20100435     Document Type: Article

References (53)

1. Belhomme, D., Peynet, J., Louzy, M., Launay, J. M., Kitakaze, M. and Menasche, P. (1999) Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 100, II340-II344.
2. Wang, X., Järvinen, O., Kuukasjärvi, P., Laurikka, J., Wei, M., Rinne, T., Honkonen, E. L. and Tarkka, M. (2004) Isoflurane produces only minor preconditioning in coronary artery bypass grafting. Scand. Cardiovasc. J. 38, 287-292.
3. Kevin, L. G., Katz, P., Camara, A. K., Novalija, E., Riess, M. L. and Stowe, D. F. (2003) Anesthetic preconditioning: effects on latency to ischemic injury in isolated hearts. Anesthesiology 99, 385-391.
4. Mio, Y., Bienengraeber, M. W., Marinovic, J., Gutterman, D. D., Rakic, M., Bosnjak, Z. J. and Stadnicka, A. (2008) Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: roles for mitochondrial respiration and sarcolemmal adenosine triphosphate-sensitive potassium channel activity. Anesthesiology 108, 612-620.
5. Tanaka, K., Kehl, F., Gu, W., Krolikowski, J. G., Pagel, P. S., Warltier, D. C. and Kersten, J. R. (2002) Isoflurane-induced preconditioning is attenuated by diabetes. Am. J. Physiol. Heart Circ. Physiol. 282, H2018-H2023.
6. Kevin, L. G., Novalija, E., Riess, M. L., Camara, A. K., Rhodes, S. S. and Stowe, D. F. (2003) Sevoflurane exposure generates superoxide but leads to decreased superoxide during ischemia and reperfusion in isolated hearts. Anesth. Analg. 96, 949-955.
7. Clermont, G., Vergely, C., Jazayeri, S., Lahet, J. J., Goudeau, J. J., Lecour, S., David, M., Rochette, L. and Girard, C. (2002) Systemic free radical activation is a major event involved in myocardial oxidative stress related to cardiopulmonary bypass. Anesthesiology 96, 80-87.
8. Ansley, D. M., Xia, Z. and Dhaliwal, B. S. (2003) The relationship between plasma free 15-F2t-isoprostane concentration and early postoperative cardiac depression following warm heart surgery. J. Thorac. Cardiovasc. Surg. 126, 1222-1223.
9. Börgermann, J., Friedrich, I., Flohé, S., Spillner, J., Majetschak, M., Kuss, O., Sablotzki, A., Feldt, T., Reidemeister, J. C. and Schade, F. U. (2002) Tumor necrosis factor-α production in whole blood after cardiopulmonary bypass: downregulation caused by circulating cytokine-inhibitory activities. J. Thorac. Cardiovasc. Surg. 124, 608-617.
10. Zhong, C., Zhou, Y. and Liu, H. (2004) Nuclear factor κB and anesthetic preconditioning during myocardial ischemia-reperfusion. Anesthesiology 100, 540-546.
11. Murphy, P. G., Myers, D. S., Davies, M. J., Webster, N. R. and Jones, J. G. (1992) The antioxidant potential of propofol (2,6-diisopropylphenol). Br. J. Anaesth. 68, 613-618.
12. Xia, Z., Godin, D. V. and Ansley, D. M. (2003) Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F2t-isoprostane formation and tissue antioxidant capacity. Cardiovasc. Res. 59, 113-121.
13. Xia, Z., Godin, D. V., Chang, T. K. and Ansley, D. M. (2003) Dose-dependent protection of cardiac function by propofol during ischemia and early reperfusion in rats: effects on 15-F2t-isoprostane formation. Can. J. Physiol. Pharmacol. 81, 14-21.
14. Ko, S. H., Yu, C. W., Lee, S. K., Choe, H., Chung, M. J., Kwak, Y. G., Chae, S. W. and Song, H. S. (1997) Propofol attenuates ischemia-reperfusion injury in the isolated rat heart. Anesth. Analg. 85, 719-724.
15. Kokita, N., Hara, A., Abiko, Y., Arakawa, J., Hashizume, H. and Namiki, A. (1998) Propofol improves functional and metabolic recovery in ischemic reperfused isolated rat hearts. Anesth. Analg. 86, 252-258.
16. Xia, Z., Godin, D. V. and Ansley, D. M. (2004) Application of high-dose propofol during ischemia improves postischemic function of rat hearts: effects on tissue antioxidant capacity. Can. J. Physiol. Pharmacol. 82, 919-926.
17. Luo, T. and Xia, Z. (2006) A small dose of hydrogen peroxide enhances tumor necrosis factor-α toxicity in inducing human vascular endothelial cell apoptosis: reversal with propofol. Anesth. Analg. 103, 110-116.
18. Kokita, N. and Hara, A. (1996) Propofol attenuates hydrogen peroxide-induced mechanical and metabolic derangements in the isolated rat heart. Anesthesiology 84, 117-127.
19. He, W., Zhang, F. J., Wang, S. P., Chen, G., Chen, C. C. and Yan, M. (2008) Postconditioning of sevoflurane and propofol is associated with mitochondrial permeability transition pore. J. Zhejiang Univ. Sci. B 9, 100-108.
20. Wang, H. Y., Wang, G. L., Yu, Y. H. and Wang, Y. (2009) The role of phosphoinositide-3-kinase/Akt pathway in propofol-induced postconditioning against focal cerebral ischemia-reperfusion injury in rats. Brain Res. 1297, 177-184.
21. Wang, B., Shravah, J., Luo, H., Raedschelders, K., Chen, D. D. and Ansley, D. M. (2009) Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation. Biochem. Biophys. Res. Commun. 389, 105-111.
22. Lim, K. H., Halestrap, A. P., Angelini, G. D. and Suleiman, M. S. (2005) Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass. Exp. Biol. Med. 230, 413-420.
23. Xia, Z., Huang, Z. and Ansley, D. M. (2006) Large-dose propofol during cardiopulmonary bypass decreases biochemical markers of myocardial injury in coronary surgery patients: a comparison with isoflurane. Anesth. Analg. 103, 527-532.
24. Flier, S., Post, J., Concepcion, A. N., Kappen, T. H., Kalkman, C. J. and Buhre, W. F. (2010) Influence of propofol-opioid vs isoflurane-opioid anaesthesia on postoperative troponin release in patients undergoing coronary artery bypass grafting. Br. J. Anaesth. 105, 122-130.
25. Tsang, A., Hausenloy, D. J. and Yellon, D. M. (2005) Myocardial postconditioning: reperfusion injury revisited. Am. J. Physiol. Heart Circ. Physiol. 289, H2-H7.
26. Amour, J., Brzezinska, A. K., Weihrauch, D., Billstrom, A. R., Zielonka, J., Krolikowski, J. G., Bienengraeber, M.W., Warltier, D. C., Pratt, Jr, P. F. and Kersten, J. R. (2009) Role of heat shock protein 90 and endothelial nitric oxide synthase during early anesthetic and ischemic preconditioning. Anesthesiology 110, 317-325.
27. Ge, Z. D., Pravdic, D., Bienengraeber, M., Pratt, Jr, P. F., Auchampach, J. A., Gross, G. J., Kersten, J. R. and Warltier, D. C. (2010) Isoflurane postconditioning protects against reperfusion injury by preventing mitochondrial permeability transition by an endothelial nitric oxide synthase-dependent mechanism. Anesthesiology 112, 73-85.
28. Xia, Z., Huang, Z., Ji, S. Y., Xia, Z. Y. and Irwin, M. G. (2009) Isoflurane and propofol synergy in reducing myocardial ischemia-reperfusion injury in patients. Anesthesiology 111, A285.
29. Thygesen, K., Alpert, J. S. and White, H. D. (2007) Universal definition of myocardial infarction. J. Am. Coll. Cardiol. 50, 2173-2195.
30. Xia, Z., Kuo, K. H., Nagareddy, P. R., Wang, F., Guo, Z., Guo, T., Jiang, J. and McNeill, J. H. (2007) N-acetylcysteine attenuates PKCβ2 overexpression and myocardial hypertrophy in streptozotocin-induced diabetic rats. Cardiovasc. Res. 73, 770-782.
31. Xia, Z., Luo, T., Liu, H. M., Wang, F., Xia, Z. Y., Irwin, M. G. and Vanhoutte, P. M. (2010) l-Arginine enhances nitrative stress and exacerbates tumor necrosis factor-α toxicity to human endothelial cells in culture: prevention by propofol. J. Cardiovasc. Pharmacol. 55, 358-367.
32. Petzold, T., Feindt, P., Sunderdiek, U., Boeken, U., Fischer, Y. and Gams, E. (2001) Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. Eur. J. Cardiothorac. Surg. 19, 859-864.
33. Sun, Y., Oberley, L. W. and Li, Y. (1988) A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34, 497-500.
34. Wasowicz, W., Neve, J. and Peretz, A. (1993) Optimized steps in fluorometric determination of thiobarbituric acid-reactive substances in serum: importance of extraction pH and influence of sample preservation and storage. Clin. Chem. 39, 2522-2526.
35. Lerman, J. (1996) Study design in clinical research: sample size estimation and power analysis. Can. J. Anaesth. 43, 184-191.
36. De Hert, S. G., Van Der Linden, P. J., Cromheecke, S., Meeus, R., ten Broecke, P. W., De Blier, I. G., Stockman, B. A. and Rodrigus, I. E. (2004) Choice of primary anesthetic regimen can influence intensive care unit length of stay after coronary surgery with cardiopulmonary bypass. Anesthesiology 101, 9-20.
37. Deyhimy, D. I., Fleming, N. W., Brodkin, I. G. and Liu, H. (2007) Anesthetic preconditioning combined with postconditioning offers no additional benefit over preconditioning or postconditioning alone. Anesth. Analg. 105, 316-324.
38. Manintveld, O. C., Hekkert, M. L., Van Der Ploeg, N. T., Verdouw, P. D. and Duncker, D. J. (2009) Interaction between pre- and postconditioning in the in vivo rat heart. Exp. Biol. Med. 234, 1345-1354.
39. Crisostomo, P. R., Wairiuko, G. M., Wang, M., Tsai, B. M., Morrell, E. D. and Meldrum, D. R. (2006) Preconditioning versus postconditioning: mechanisms and therapeutic potentials. J. Am. Coll. Surg. 202, 797-812.
40. Lebuffe, G., Schumacker, P. T., Shao, Z. H., Anderson, T., Iwase, H. and Vanden Hoek, T. L. (2003) ROS and NO trigger early preconditioning: relationship to mitochondrial KATP channel. Am. J. Physiol. Heart Circ. Physiol. 284, H299-H308.
41. Pagel, P. S. (2007) When lack of addition really does add up. Anesth. Analg. 105, 1863.
42. Toller, W. G., Kersten, J. R., Pagel, P. S., Hettrick, D. A. and Warltier, D. C. (1999) Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Anesthesiology 91, 1437-1446.
43. Obal, D., Dettwiler, S., Favoccia, C., Scharbatke, H., Preckel, B. and Schlack, W. (2005) The influence of mitochondrial KATP-channels in the cardioprotection of preconditioning and postconditioning by sevoflurane in the rat in vivo. Anesth. Analg. 101, 1252-1260.
44. Mouithys-Mickalad, A., Hans, P., Deby-Dupont, G., Hoebeke, M., Deby, C. and Lamy, M. (1998) Propofol reacts with peroxynitrite to form a phenoxyl radical: demonstration by electron spin resonance. Biochem. Biophys. Res. Commun. 249, 833-837.
45. Kahraman, S. and Demiryurek, A. T. (1997) Propofol is a peroxynitrite scavenger. Anesth. Analg. 84, 1127-1129.
46. Novalija, E., Varadarajan, S. G., Camara, A. K., An, J., Chen, Q., Riess, M. L., Hogg, N. and Stowe, D. F. (2002) Anesthetic preconditioning: triggering role of reactive oxygen and nitrogen species in isolated hearts. Am. J. Physiol. Heart Circ. Physiol. 283, H44-H52.
47. Lefer, D. J., Scalia, R., Campbell, B., Nossuli, T., Hayward, R., Salamon, M., Grayson, J. and Lefer, A. M. (1997) Peroxynitrite inhibits leukocyte-endothelial cell interactions and protects against ischemia-reperfusion injury in rats. J. Clin. Invest. 99, 684-691.
48. Altug, S., Demiryurek, A. T., Kane, K. A. and Kanzik, I. (2000) Evidence for the involvement of peroxynitrite in ischaemic preconditioning in rat isolated hearts. Br. J. Pharmacol. 130, 125-131.
49. Wang, H. C., Zhang, H. F., Guo, W. Y., Su, H., Zhang, K. R., Li, Q. X., Yan, W., Ma, X. L., Lopez, B. L., Christopher, T. A. and Gao, F. (2006) Hypoxic postconditioning enhances the survival and inhibits apoptosis of cardiomyocytes following reoxygenation: role of peroxynitrite formation. Apoptosis 11, 1453-1460.
50. Wang, X. L., Liu, H. R., Tao, L., Liang, F., Yan, L., Zhao, R. R., Lopez, B. L., Christopher, T. A. and Ma, X.L. (2007) Role of iNOS-derived reactive nitrogen species and resultant nitrative stress in leukocytes-induced cardiomyocyte apoptosis after myocardial ischemia/reperfusion. Apoptosis 12, 1209-1217.
51. Lopez, B. L., Liu, G. L., Christopher, T. A. and Ma, X. L. (1997) Peroxynitrite, the product of nitric oxide and superoxide, causes myocardial injury in the isolated perfused rat heart. Coron. Artery Dis. 8, 149-153.
52. Bird, R. P., Hung, S. S., Hadley, M. and Draper, H. H. (1983) Determination of malonaldehyde in biological materials by high-pressure liquid chromatography. Anal. Biochem. 128, 240-244.
53. Kilcullen, N., Viswanathan, K., Das, R., Morrell, C., Farrin, A., Barth, J. H. and Hall, A. S. (2007) Heart-type fatty acid-binding protein predicts long-term mortality after acute coronary syndrome and identifies high-risk patients across the range of troponin values. J. Am. Coll. Cardiol. 50, 2061-2067.